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Adjusted Likelihoods for Synthesizing
Empirical Evidence from Studies that
Differ in Quality and Design: Effects of
Environmental Tobacco Smoke
Robert L. Wolpert and Kerrie L. Mengersen
Abstract. Methods are introduced and illustrated for synthesizing evidence
from case-control and cohort studies, and controlled trials, accounting for
differences among the studies in their design, length of follow-up and quality.
The methods, based on hierarchical but nonexchangeable Bayesian models,
are illustrated in a synthesis of disparate information about the health effects
of passive exposure to environmental tobacco smoke.
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1. INTRODUCTION
The hazards of combining evidence naïvely from
multiple sources are well known. Even among sources
intended to be homogeneous, such as multi-center con-
trolled medical trials, there will be some variation in
patient attributes and treatment regimens. This varia-
tion is strongly exacerbated in epidemiological studies
because of differing study designs and methods, and
differing population characteristics: designs may vary
according to their retrospective or prospective nature,
their case-control, cohort or cross-sectional structure,
length of follow-up, admission and classification cri-
teria, control of biases, consideration of confounders
and data collection procedures. Study populations vary
in age structure, diet and other lifestyle factors, genetic
makeup, and environmental exposure to competing and
contributing risks. Investigators also vary with respect
to experience, motivation and skill. All of these issues
threaten the validity of methods which simply pool
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the data. Methods which are sensitive to the probabil-
ity distributions that govern the individual studies’ ob-
served outcomes can make more complete use of study
information and so can lead to more powerful statisti-
cal tests and to shorter credible intervals for uncertain
parameters.
Beginning with Fisher’s (1934) early attempt to
avoid the problem of heterogeneity in field trials by
combining individual p values to assess the overall
significance level, a number of authors have introduced
novel statistical methods intended to quantify an over-
all “effect size” and assess its variation. These meth-
ods, referred to collectively as meta-analysis, have
been described and compared by many authors, in-
cluding Hedges and Olkin (1985) and the National Re-
search Council review (1992).
More recently Bayesian and Bayesian-inspired
methods have been brought to bear on the meta-
analysis problem, starting with the landmark papers
by DuMouchel and Harris (1983), who introduced
the idea of constructing hierarchical Bayesian mod-
els to synthesize information from five types of envi-
ronmental studies of the effect on human and animal
subjects of exposure to nine related environmental
agents, and Dempster, Selwyn and Weeks (1983),
who synthesized historical and contemporary clini-
cal evidence. Subsequent authors who offered broad
guides to the use of Bayesian hierarchical models for
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synthesizing evidence include Berry (1990), Carlin
(1992), DuMouchel (1990, 1996), Higgins and
Spiegelhalter (2002), Liao (1999), who combined 2×2
tables, Morris and Normand (1992), Normand (1999),
Smith, Spiegelhalter and Parmar (1996), Spiegelhalter,
Thomas, Best and Lunn (2002, in the BUGS software
examples) and Sutton and Abrams (2001). All of these
approaches make at least some accommodation for
study heterogeneity, commonly through inclusion of
a single extra variance term in the hierarchical model
structure, but each treats all the studies as exchangeable
(at least within groups).
In many meta-analytic applications the simplifying
assumption of exchangeability (de Finetti, 1930) is
simply untenable—studies differ too much in their
designs, subject selection criteria or other details for
any analysis that ignores these differences to be con-
vincing. One approach would be to quantify how sim-
ilar the different studies are to each other (Draper,
Hodges, Mallows and Pregibon, 1993) or how similar
they are to the target circumstances, and then exclude
or discount in ad hoc ways those studies regarded as too
dissimilar. Another approach, due to Eddy (1989), is to
replace each study’s likelihood function with a subjec-
tive estimate of “what would have been observed” had
that study followed the target circumstances exactly.
Eddy coined the term “adjusted likelihood function”
for these replacements, a term we employ in our own
(related) approach introduced in Section 2 below.
We propose a different approach: the construction
of a hierarchical Bayesian model with submodels, for
each study or other source of evidence, that reflect and
accommodate important study-specific differences. In
this coherent approach the investigator begins by spec-
ifying in detail the target conditions—for example, the
subject population, treatment or exposure details, and
case or outcome details. Each individual study offers
direct evidence through its likelihood function about
the parameters that govern that particular study, with
its specific design, selection criteria, and so forth. We
construct an adjusted likelihood function that describes
the indirect evidence offered by each study about the
questions of interest to the investigator under the spec-
ified target conditions. Studies conducted under condi-
tions quite similar to the target conditions lend strong
evidence; studies less similar lend more uncertain ev-
idence, leading in a natural way for them to be dis-
counted appropriately in an overall synthesis.
1.1 Evidence from Individual Studies
Epidemiological studies offer direct evidence about
the conditional probabilities of outcome status (for co-
hort studies) or exposure (for case-control studies) for
the study populations and, through these, indirect evi-
dence about the quantity of interest: usually, some mea-
sure of the association between exposure and outcome
within the entire population. Evidence is often avail-
able about the size and impact of varying age distrib-
utions, misclassification rates, and other confounding
features and possible biases, but this evidence is rarely
used in analyses. The methodology we present offers
an opportunity to exploit this evidence.
In a cohort study (CHS) subjects are drawn from a
specified population and classified as exposed or un-
exposed (Breslow and Day, 1987). They are then fol-
lowed for a specified length of time and classified with
respect to their disease status. Such studies may be con-
ducted prospectively or retrospectively. Evidence bears
directly on the conditional probabilities of becoming
a case, pc|e and pc|e¯, in the exposed and unexposed
study arms, respectively, through the likelihood func-
tion (Berger and Wolpert, 1988). In the simple case
where age and other covariates are not considered this
is
LCHS(pc|e,pc|e¯)
(1)
∝ (pc|e)nce (1 − pc|e)nc¯e (pc|e¯)nce¯ (1 − pc|e¯)nc¯e¯ ,
where nce and nc¯e are the numbers of cases and non-
cases among the ne exposed subjects, and nce¯ and nc¯e¯
are the numbers of cases and noncases among the
ne¯ unexposed subjects, respectively. Occasionally these
conditional probabilities may themselves be useful, but
more often interest lies in some measure of their dif-
ference quantifying the association between outcome
and exposure, such as the simple difference εSD =
pc|e − pc|e¯, log relative risk εLRR = log(pc|e/pc|e¯) or
log odds ratio
εLOR = log(pc|e pc¯|e¯/pc¯|e pc|e¯).
Each of these measures will be positive if greater expo-
sure is associated with higher levels of disease and zero
if they are unrelated, and each can be estimated in a co-
hort study by its maximum likelihood estimator (MLE)
such as εˆLOR = log(nce nc¯e¯/nce¯ nc¯e). These and other
measures have been discussed, illustrated and com-
pared by many authors, including Breslow and Day
(1980, Chapter 2), Cox (1970, page 20), Freeman
(1987, pages 66 and 95) and Wolpert (1986).
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A variety of methods (see Berger, Liseo and Wolpert,
1999) have been proposed for extracting information
about a quantity of interest like ε amid nuisance para-
meters; the Bayesian approach is to select a conditional
prior distribution π(dp |ε) for p = (pc|e,pc|e¯) and
summarize the evidence about ε alone by LCHS(ε) =∫
LCHS(p)π(dp|ε). A change of variables to the log
odds ratio ε = εLOR and independent Jeffreys’ reference
priors for both case probabilities pc|e and pc|e¯ leads to
the likelihood
LCHS(ε) ∝ ε−1(eε − 1)enceε
·
∫ 1
0
pnc(1 − p)nc¯
[1 − p(1 − eε)]ne+1 dp(2)
∝ ε−1(eε − 1)enceε
· 2F1(ne + 1, nc + 1;n + 2;1 − eε),
where 2F1(a, b; c; z) is the confluent hypergeometric
function (Abramowitz and Stegun, 1964, page 558).
With the implied prior π(ε) = ε/2π2 sinh(ε/2), the log
odds ratio εLOR has posterior mean and variance
µ = ψ(nce + 1/2) − ψ(nc¯e + 1/2)
− ψ(nce¯ + 1/2) + ψ(nc¯e¯ + 1/2)(3)
≈ log(ncenc¯e¯/nc¯ence¯),
σ 2 = ψ ′(nce + 1/2) + ψ ′(nc¯e + 1/2)
+ ψ ′(nce¯ + 1/2) + ψ ′(nc¯e¯ + 1/2)(4)
≈ 1/nce + 1/nc¯e + 1/nce¯ + 1/nc¯e¯,
where ψ(z+1/2) = log z+O(z−2) and ψ ′(z+1/2) =
1/z+O(z−3) are the digamma and trigamma functions
(Abramowitz and Stegun, 1964, Section 6.3.4).
For example, Figure 1 shows LCHS(ε) for the famous
1985 extracorporeal membrane oxygenation (ECMO)
trial (see Ware, 1989), in which 6 of 10 subjects sur-
vived in the control group and 9 of 9 survived who
were “exposed” to ECMO. The solid line is LCHS(ε)
from (2), the dashed line is the marginal prior density
function π(ε) and the vertical bar at εLOR = 0 marks
the null effect. The posterior probability of greater risk
for ECMO is P[εLOR > 0] ≈ 0.0107 with this prior (see
Kass and Greenhouse, 1989 and Lavine, Wasserman
and Wolpert, 1991, for discussions of prior distribu-
tions for this problem).
For less extreme contingency tables, including all
of those in the environmental tobacco smoke (ETS)
case study considered below, the distribution is very
well approximated by a normal with the same mean
FIG. 1. Marginal likelihood (solid ) and prior density (dashed )
for odds ratio of survival R = exp(εLOR) in the 1985 ECMO trial
(on log scale).
and variance or with the approximate means and vari-
ances given in (3) and (4) above. Similar expressions
are available for the other measures of exposure effect
in cohort studies.
Similarly, in a case-control study (CCS) some num-
ber nc of cases are matched with nc¯ noncases (controls)
on the basis of demographic variables and other covari-
ates (Breslow and Day, 1980), and then within each of
these groups subjects are further classified into those
who are exposed (nce, nc¯e) and unexposed (nce¯, nc¯e¯).
Such a study can offer direct evidence only about the
conditional probabilities of exposure within case and
noncase groups, pe|c and pe|c¯, through the likelihood
function
LCCS(pe|c,pe|c¯)
(5)
∝ (pe|c)nce (1 − pe|c)nce (pe|c¯)nc¯e (1 − pe|c¯)nc¯e¯ .
Only indirect evidence is given about the remaining
probabilities. Independent reference priors for the un-
observed exposure probabilities pe|c¯ and pe|c lead to
an adjusted likelihood function
LCCS(ε) ∝ ε−1(eε − 1)enceε
(6)
· 2F1(nc + 1, ne + 1;n + 2;1 − eε),
again approximately normal with mean µ ≈
log(ncenc¯e¯/nc¯ence¯) and variance σ 2 ≈ 1/nce+1/nce¯+
1/nc¯e + 1/nc¯e¯.
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1.2 Exchangeable Combination of Evidence
If study subjects comprise a simple random sam-
ple from some population, then both cohort studies
and case-control studies give evidence about the same
vector θ = (θce, θce¯, θc¯e, θc¯e¯) of probabilities that an
eligible subject drawn randomly from the target popu-
lation will be an exposed or unexposed case, exposed
or unexposed noncase, respectively, through their re-
spective likelihood functions LCHS(pc|e,pc|e¯) (since
pc|e = θce/θe, pc|e¯ = θce¯/θe¯) and LCCS(pe|c,pe|c¯)
(since pe|c = θce/θc, pe|c¯ = θc¯e/θc¯). Hence, it is con-
venient to express all studies’ evidence in terms of θ
before trying to combine them across study types.
Evidence about a common parameter vector θ may
be captured from a set of I independent studies through
the joint likelihood function LI (θ) =∏i∈I Li(θ). For
case-control studies, for example, this is equivalent to
observing n+ce ≡
∑
i∈I nice exposed and n+ce¯ ≡
∑
i∈I nice¯
unexposed cases, n+c¯e ≡
∑
i∈I nic¯e exposed and n
+
c¯e¯ ≡∑
i∈I nic¯e¯ unexposed noncases in a single pooled study.
However, in most cases, the underlying assumption of
exactly the same conditional probabilities in all I stud-
ies is just not reasonable. The studies almost always
differ in important respects that affect their probabili-
ties of exposure and outcome, and hence their evidence
about θ . The effect of ignoring this variation is system-
atically to underrepresent uncertainty in the posterior
distribution and sometimes to distort the location of the
distribution as well.
A first step toward accommodating study varia-
tion is to allow the conditional case (resp., exposure)
probabilities pc|e¯, pc|e (resp., pe|c,pe|c¯) to vary across
studies, while still treating the measure of interest ε
as constant across all studies. Changing variables to
ε = εLOR and pic|e¯ for cohort studies and pie|c¯ for case-
control studies leads to
LICHS(ε,p
I
c|e¯)
∝ eεn+ce ∏
i∈I
[
(pic|e¯)n
i
c (1 − pic|e¯)n
i
c¯(7)
· [1 − pic|e¯(1 − eε)]−n
i
e
]
,
LICCS(ε,p
I
e|c¯)
∝ eεn+ce ∏
i∈I
[
(pie|c¯)n
i
e (1 − pie|c¯)n
i
e¯(8)
· [1 − pie|c¯(1 − eε)]−n
i
c
]
and in each case to LI (ε) = ∫ L(ε,pI )π(dpI |ε) for
evidence about ε (for independent Jeffreys’ prior dis-
tributions, e.g.) to
LIFE(ε) ∝
ε|I |en+ceε
(eε − 1)|I |(9)
·∏
i∈I
2F1(n
i
c + 1, nie + 1;ni + 2;1 − eε),
which is approximately normal again, but now with
mean µFE ≈ ∑i∈I µiσ−2i /∑i∈I σ−2i and variance
σ 2FE ≈ 1/
∑
i∈I σ−2i , the precision-weighted mean of
the sample means µi ≈ log(nicenic¯e¯/nic¯enice¯) using vari-
ances σ 2i ≈ [1/nice + 1/nic¯e + 1/nice¯ + 1/nic¯e¯]. This is
the familiar fixed-effects model. The best choice of
π(dp|ε) depends on the application. In the example
presented in Section 3, both reference and informed
prior distributions are illustrated.
While some invariance may be offered by using a
measure of exposure effect that is thought to be rel-
atively insensitive to study variation (e.g., using εLOR
if the variations are expected to scale incidence odds
by equal factors; see Wolpert, 1986), possible variation
across studies in the effect measures εi should be mod-
eled explicitly. If we take εi ∼ No(ε, σ 2), for example,
independent normal variates with common unknown
mean ε and known variance σ 2, and ascribe a diffuse
conjugate prior distribution ε ∼ No(µ, τ 2), the earlier
normal approximations to LCHS(εLOR) and LCCS(εLOR)
lead to the familiar random-effects model whose ap-
proximately normal posterior distribution has mean
µRE ≈∑i∈I µi(σ 2 +σ 2i )−1/(τ−2 +∑i∈I (σ 2 +σ 2i )−1)
and variance σ 2RE ≈ 1/(τ−2 +
∑
i∈I (σ 2 + σ 2i )−1),
with the same study-specific µi and σ 2i as above.
Uncertainty about hyperparameters τ 2 and σ 2 is re-
flected through prior distributions in the case study
presented in Section 3. Note that the fixed-effects
model may be recovered in the limit as σ 2 → 0,
τ 2 → ∞.
It is a small generalization of the random-effects
model to describe the variation in study-specific pa-
rameters pi explicitly. Modeling them as exchange-
able is equivalent (by de Finetti’s theorem) to treating
them as conditionally independent identically distrib-
uted random vectors, given an overall hyperparame-
ter θ . If the exposure effect ε can be written as a
function of θ (or, more generally, if ε is conditionally
independent of the {pi}, given θ ), then the joint prior
distribution for ε, θ , and all the {pi} can be factored
as π(dε)π(dθ |ε)∏i∈I π(dpi |θ), giving the marginal
likelihood for the exposure effect the representation
LIEHM(ε) =
∫ [∏
i∈I
∫
Li(pi)π(dpi |θ)
]
π(dθ |ε).(10)
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This reduces to the random-effects model for θ ≡
(µ, τ, σ ) and normal logistic conditional distributions
π(dpi |θ); to the fixed-effects model for θ ≡ ε and beta
conditional distributions π(dpic|e¯|θ), π(dpie|c¯|θ); and
to simple pooling for θ ≡ (pce,pce¯, pc¯e,pc¯e¯) with unit
point masses π(dpi |θ) at pi = θ .
1.3 Partially Exchangeable Combination
of Evidence
Sometimes studies can be regarded as exchangeable
within known groups, but the groups may differ sys-
tematically among themselves. Health care at urban
and rural facilities may differ, for example, or educa-
tional performance at public and private schools or uni-
versities. The possible effects of ETS exposure in the
example in Section 3 can be expected to differ across
different countries for any number of reasons (compet-
ing risks, differing levels of exposure, geographically
varying genetic propensities, etc.). In the simplest form
the groups may themselves be treated as exchangeable,
leading to a multistage partially exchangeable hierar-
chical model of the form
ε ∼ π(dε), θ ∼ π(dθ |ε),
θg ∼ π(dθg|θ), g ∈ G,
θi ∼ π(dθi |θg), i ∈ g,
where g ∈ G indexes the groups and i ∈ g indexes the
studies within a group, and where each given distri-
bution is (implicitly) conditionally independent of all
parameters higher in the hierarchy. Now
LIPEM(ε)
=
∫ {∏
g∈G
∫ [∏
i∈g
∫
Li(θ
i)π(dθi |θg)
]
π(dθg|θ)
}
· π(dθ |ε).
For example, normal prior distributions at each stage
could lead to the model ε ∼ No(0, τ 2), εg ∼ No(ε, σ 2g ),
g ∈ G, εi ∼ No(εg, σ 2i ), i ∈ g, for the exposure ef-
fect ε (with suitable conditional distributions for θi ,
given εi ), where σ 2g and σ 2i are the group-level and
individual-level prior variances and τ 2 is the large vari-
ance of the diffuse prior for the overall effect ε, al-
lowing for greater homogeneity among studies within
groups.
2. SYNTHESIZING HETEROGENEOUS EVIDENCE
Studies vary in the degree to which confounding ef-
fects and possible biases have been recognized and ac-
commodated, and in the levels of similarity between
their subject populations and the study population. The
five synthesis methods presented in Section 1 (simple
pooling, fixed- and random-effect models, and fully
and partially exchangeable hierarchical models) allow
for increasing degrees of heterogeneity among studies,
but they do not make use of collateral evidence about
the size and impact of varying age and exposure dis-
tributions, misclassification rates and other differences
that might be expected to affect the evidence.
Several methods have been proposed for discount-
ing evidence thought to be less reliable or to apply less
directly to the questions of interest in meta-analysis,
some of which were first developed to address the sim-
ilar problems that arise in synthesizing the opinions of
several experts (Makridakis and Winkler, 1983; Gen-
est and Zidek, 1986; Wolpert, 1989). These include
threshold exclusion, in which studies thought to be
less applicable are simply excluded from the analysis;
weighted likelihood functions; block mixtures, in which
groups of studies of comparable quality or applicabil-
ity are successively included in the analysis; mixtures,
in which individual studies are included in the analysis
with probabilities based on their relative applicability;
and hierarchical models, in which treatment effects are
estimated separately for homogeneous groups of stud-
ies, to reveal systematic variation of apparent effects
across groups.
This paper investigates another alternative, intended
to extract, reconcile and synthesize information about
a quantity of interest despite study variations and
flaws: the systematic adjustment of the different studies
within the Bayesian paradigm to accommodate (and,
where possible, correct for) their differences from one
another and from the intended object of study.
2.1 Adjustment
A common problem in synthesizing evidence is that
of making inference about the parameter θ0 that would
govern an ideal (or paradigm) study for a particu-
lar purpose—one for the population of interest to the
investigator, without misclassification or other weak-
nesses, on the basis of nonideal studies whose con-
ditions vary in important ways from the ideal. If the
ith study offers direct evidence about a parameter θi
through a likelihood Li(θ i), and if each θi (includ-
ing θ0) is related to a hyperparameter θ through a
known functional relationship θi = φi(θ), then we can
“adjust” the evidence from the ith study to bear directly
on θ (and hence on θ0) through the relationship
L
Adj
i (θ) = Li(φi(θ)),(11)
ADJUSTED LIKELIHOODS FOR SYNTHESIZING EVIDENCE 455
where the arbitrary function φi(θ) represents the value
of θi when the hyperparameter value is θ .
If the analyst studying a series of clinical trials be-
lieves that the success probability in the ith trial should
be only a fraction (say, half ) of the success proba-
bility θ0 under paradigm conditions, perhaps because
half of the subjects in that trial were noncompliant,
then s/he might take θ0 = φ0(θ) = θ and set θi =
φi(θ) = θ/2 for that trial. Of course, this choice im-
plies that the joint prior probability distribution for the
pair (θ, θ i) is concentrated on the one-dimensional set
{(θ, θ i) : 0 ≤ θi ≤ 1/2, θ = 2θi} and in particular that
θi ≤ 1/2. Similarly, one analyzing a series of cohort
studies might use φi(θ) = 0.9θ + 0.1θ∗ if 10% of the
subjects were thought to be misclassified from a group
with event probability θ∗ rather the paradigm probabil-
ity θ0 = θ .
A useful generalization is the parametric adjustment
model in which the adjustment function θi = φ(θ,αi)
depends explicitly on a parameter αi , leading to
L
Adj
i (θ) = Li(φ(θ,αi)).(12)
For example, we may allow an arithmetic shift in
the binomial success probability parameter θ by set-
ting φ(θ,αi) = θ + αi , or a logistic shift by spec-
ifying φ/(1 − φ) = eαi θ/(1 − θ), that is, φ(θ,αi) =
θeαi /[θeαi + 1 − θ ].
Although (12) offers no real increase in generality
over the nonparametric adjustments made in (11), it is
often easier (in our experience) to elicit expert opin-
ion about parameter values than about transformation
functions. Several examples illustrate the parametric
adjustment approach below.
If the parameter αi in (12) is regarded as uncertain
and, therefore (in the Bayesian context), random with
a prior probability distribution παi (dαi |θ), then we can
form a conditional distribution for θi given θ by aver-
aging (12) over the possible values of αi ,
πi(dθ
i |θ) =
∫
δ
(
θi − φi(θ,αi))παi (dαi |θ),
and an adjusted likelihood function
L
Adj
i (θ) =
∫
Li(θ
i)πi(dθ
i |θ)
(13)
=
∫
Li(φ(θ,αi))π
α
i (dαi |θ).
It is important not to use a noninformative prior for αi ,
since this ordinarily results in a constant likelihood
function LAdji (θ) that lends no evidence whatsoever
about θ . This is the mathematical reflection of the fact
that an instrument whose bias or scale is entirely un-
known can give no evidence about a measured quan-
tity.
2.2 Specific Examples of Adjustment
In this section we examine two specific examples of
adjustments, each of the parametric or uncertain type
described above, to illustrate the concepts.
In both case-control and cohort studies, each subject
is classified three times: once when assessing eligibil-
ity, once when assessing exposure and once when as-
sessing outcome (case or noncase status). Thus three
fundamentally different sorts of classification error
may affect the analysis: eligibility violation, exposure
misclassification and case misclassification.
Anticipating the passive smoking application of Sec-
tion 3, in which current or former smokers are ineligi-
ble, we denote by pijk
 the (true) fraction of the ith
study population with case status j ∈ C ≡ {c, c¯} (case
and noncase), exposure status k ∈ E ≡ {e, e¯} (exposed
and unexposed) and eligibility status 
 ∈ S ≡ {s, s¯}
(ineligible, i.e., ever-smoker, and eligible, i.e., never-
smoker).
Interest centers on the vector θi = (θ ice, θ ice¯, θ ic¯e, θ ic¯e¯)
of true classification probabilities {θij ≡ pij |s¯}j∈CE of
eligible (never-smoking) subjects, but through study
designs and classification errors the studies give direct
evidence only on the apparent classification probabil-
ities {qice, qice¯, qic¯e, qic¯e¯} of the ostensibly eligible sub-jects admitted to the study, including both those who
are truly eligible and those who are not.
2.2.1 Eligibility violation. Under both CCS and
CHS designs, eligibility criteria may be subjective or
may be based on information which is potentially inac-
curate. Eligibility violations can distort evidence, par-
ticularly if violation rates differ across study arms. If
the probability αis¯|js that an ineligible individual in the
ith population of true classification j ∈ CE will appear
to be eligible is greater than 0 or if the probability αis¯|j s¯
that an eligible individual will be recognized as eligible
is less than 1, then the classification probabilities {qij }
for ostensibly eligible subjects will differ from those
{θij } for truly eligible ones:
qij = αis¯|jspijs + αis¯|j s¯pij s¯(14)
= αis¯|jspijs + αis¯|j s¯θ ijpis¯ .
This is a parametric adjustment θi = φ(θ,αi) of the
form of (12) for the parameter vector αi ≡ (αis¯|j
,
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pijs)j∈CE ,
∈S . The experimenter may specify particular
values for the eligibility misclassification probabilities
and ineligible-subject classification probabilities or, as
in (13), may reflect uncertainty about them through in-
formative or even reference conditional prior probabil-
ity distributions.
2.2.2 Misclassification of exposure and disease. In
studies of both CHS and CCS design a true case might
be misclassified as a noncase or vice versa. Similar
errors may arise in ascertaining or recording a sub-
ject’s exposure status. Thus a subject in any of the
four case–exposure classes CE = {ce, ce¯, c¯e, c¯e¯} in a
CHS or CCS might be misclassified in any of the
other classes. Denote by αij |k the conditional proba-
bility that a subject in study i of true case–exposure
class k will be classified to class j , for each j, k ∈ CE .
If the true case–exposure class probabilities for ran-
domly drawn subjects from the population under study
in study i are pi ≡ (pice,pice¯, pic¯e, pic¯e¯), the study will
give only indirect evidence about pi through like-
lihood function Li(qi), which gives direct evidence
about the apparent classification probabilities qi ≡
(qice, q
i
ce¯, q
i
c¯e, q
i
c¯e¯) given by
qij =
∑
k
αij |kpik.(15)
The 8 × 8 classification probability matrix αij |k ,
j, k ∈ CES, would be the identity matrix for a study
without classification errors, but in general must be ex-
pected to have some nonzero off-diagonal elements.
If multiple classification errors are regarded as neg-
ligibly likely, then αij |k will require that up to eight
misclassification probabilities be specified for each
study; we illustrate this for the ETS example in Sec-
tions 3.2.3 and 3.2.4.
3. IS EXPOSURE TO ETS ASSOCIATED WITH
LUNG CANCER IN FEMALE NONSMOKERS?
Whether or not exposure to other people’s tobacco
smoke, or passive smoking, is harmful to health is an
issue which has been widely debated over the past
decade and which has broad implications in current
tort and public policy decisions. An important open
question remains about the impact of study quality on
individual study results and on the overall body of
evidence. Because lung cancer is a rare disease among
never-smokers, and the possible effects under study
are small, possible biases and misclassification have
not been ruled out entirely as explanations for any ob-
served increase in relative risk of deleterious health ef-
fects for those thought to be exposed to environmental
tobacco smoke (ETS). Three main quality issues are
commonly identified as influential in the analysis of the
association between ETS exposure and lung cancer in
adults who have never smoked:
1. Misclassification of ever-smokers as never-smokers.
Lung cancer rates are known to be much higher
among ever-smokers than among never-smokers
(whether or not exposed to ETS) and ever-smokers
are more likely to have smoking spouses than never-
smokers (the so-called marriage concordance). Thus
there is concern that the inclusion of active or for-
mer smokers in a study of never-smokers may lead
to a systematic overstatement of the effect of ETS
exposure. The debate over the effect of this issue
has been lively. While some investigators such as
Wu (1999) and Boffetta et al. (1998) argued that the
bias is unlikely to explain the observed excess risk,
others such as Lee and Forey (1999) disagreed.
2. Misclassification of disease. The degree to which
disease classification is verified histologically dif-
fers markedly among studies, and errors in di-
agnosis of lung cancer deaths based on death
certificates or clinical diagnoses are widely recog-
nized (Lee, 1992, pages 128–129; Table 23.3,
page 87). McFarlane, Feinstein and Wells (1986)
reported that such misclassification is differential
between active smokers and nonsmokers, but Lee
(1992, page 129) countered that these differentials
have not been established for those exposed or un-
exposed to ETS.
3. Misclassification of exposure. The measure of expo-
sure to ETS is most often indirect and inadequate,
leading to speculation about under- or overreport-
ing and possible misclassification as “exposed” or
“unexposed.” Most studies in our data set adopt
“married to a smoker” as a surrogate measure of
exposure and do not use any objective measure of
exposure (such as cotinine analysis, which itself is
prone to criticism since it measures only recent ex-
posure). LeVois and Switzer (1998) suggested that
variation of this misclassification rate with case sta-
tus may lead to spuriously high observed relative
risk.
The Environmental Protection Agency (EPA Review,
1992) and Lee (1992) provide comprehensive dis-
cussions and literature reviews of these problems for
31 studies available at that time, of which relevant data
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are available for 29. As a result, we focus on this
data set and exclude more recent studies for which
such data are unavailable. In Section 5 we show that
this does not limit the relevance of our conclusions to
the present debate.
The 29 studies are summarized in Table 1, based on
the EPA Review (1992, Tables 5-1 and 5-2) and Lee
(1992, Table 3.13), where primary references appear.
Studies are categorized into quality tiers (1 = best;
4 = worst) by the EPA Review to reflect the study-
specific level of care taken to control for various qual-
ity issues. The tier for each study was based on a sum
of penalty points (ranging from −0.5, a bonus, to as
high as +2.5) awarded in each of 19 categories, in-
cluding eligibility (never-smoker status confirmation),
explicit ETS-exposure criteria, lung cancer indication,
interview type, proxy respondents, follow-up, design
issues and analysis issues (control of age, control of
other confounders, statistical methods). Studies in the
lowest (fourth) tier were regarded by the EPA Review
as unsuitable for inclusion in a meta-analysis.
Study heterogeneity was acknowledged in the EPA
Review by undertaking meta-analyses within but not
across country groups (Greece, Hong Kong, Japan,
United States, Western Europe, China). They em-
ployed a fixed-effects model, with the explicit assump-
TABLE 1
Twenty-nine studies of the association between lung cancer and exposure to spousal smoking among
never-smoking females
Cases Noncases
Exp Unexp Exp Unexp Qual
tierb
Ctry
grpbStudies Yearsa nce nce¯ nc¯e nc¯e¯
Case control
1 Akiba et al. (1986) 71–80 73 21 188 82 2 JP
2 Brownson et al. (1987) 79–82 4 15 6 41 3 US
3 Buffler et al. (1984) 76–80 33 8 164 32 3 US
4 Chan and Fung (1982) 76–77 34 50 66 73 4 HK
5 Correa et al. (1983) 79–82 14 8 61 72 2 US
6 Fontham et al. (1991) 85–88 294 126 492 288 1 US
7 Gao et al. (1987) 84–86 189 57 276 99 3 CN
8 Garfinkel et al. (1985) 71–81 91 43 254 148 2 US
9 Geng et al. (1988) 83–83 34 20 41 52 4 CN
10 Humble et al. (1987) 80–84 15 5 91 71 2 US
11 Inoue and Hirayama (1988) 73–83 18 4 30 17 4 JP
12 Kabat and Wynder (1984) 61–80 13 11 15 10 2 US
13 Kalandidi et al. (1990) 87–89 65 26 74 46 1 GR
14 Koo et al. (1987) 81–83 51 35 66 70 1 HK
15 Lam, T. et al. (1987) 83–86 115 84 152 183 2 HK
16 Lam, W. (1985) 81–84 37 23 64 80 3 HK
17 Lee et al. (1986) 79–82 22 10 45 21 2 EU
18 Liu et al. (1991) 85–86 45 9 176 26 4 CN
19 Pershagen et al. (1987) 61–80 37 33 153 141 1 EU
20 Shimizu et al. (1988) 82–85 52 38 91 72 2 JP
21 Sobue et al. (1990) 86–88 80 64 395 336 2 JP
22 Svensson et al. (1989) 83–85 24 10 114 60 2 EU
23 Trichopoulos et al. (1983) 78–80 53 24 116 109 3 GR
24 Wu et al. (1985) 81–82 19 10 38 24 2 US
25 Wu-Williams et al. (1990) 85–87 205 212 331 271 4 CN
Cohort
26 Butler (1988) 76–82 3 5 3128 6071 2 HK
27 Garfinkel (1981) 59–72 88 65 94792 81794 3 US
28 Hirayama (1984) 65–81 163 37 69482 21858 2 JP
29 Hole et al. (1989) 72–85 5 1 1290 488 1 EU
SOURCE: EPA Review (1992), Tables 5-1 and 5-2; Lee (1992), Table 3.13.
aYears refers to each study’s case accrual period.
bDescribed in the text.
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tion that studies within country groups are relatively
homogeneous with respect to exposure, incidence,
risk and other confounders (EPA Review, 1992,
pages 5–31). The impact of study quality is inves-
tigated through cumulative meta-analyses of studies
in the various quality tier ranges (Tier 1, Tiers 1–2,
Tiers 1–3), again within country groups. For some
country groups, the overall relative risk was inflated
with the addition of poorer quality studies, while for
other groups the reverse occurred. For example, an
estimate of 1.92 (90% CI 1.13–3.23) was reported
for Tier 1–2 studies in Greece, compared to 2.01
(1.42–2.84) based on all studies in this country group,
while respective figures for the USA country group
were 1.23 (1.04–1.42) and 1.19 (1.04–1.35).
In further analyses the EPA Review pays specific
attention to the quality issue of misclassification of
active smokers as never-smokers. Unlike previous ad-
justments (Wald, Nanchahal, Thompson and Cuckle,
1986; National Research Council Committee on Pas-
sive Smoking, 1986), in which only the overall relative
risk was adjusted following analysis, the EPA Review
(1992) computed “corrected” relative risk estimates for
each study and the consequent bias expressed as a ra-
tio of the corrected and uncorrected estimates (EPA
Review, 1992, Table 5-8). The underlying methodol-
ogy, due to Wells and Stewart (Wells, 1990), is based
on misclassification rates found in a small number
of cotinine studies and studies of discordant answers.
Different (and larger) biases were found by Lee (see
discussion pages B-3–B-4, EPA Review, 1992), using
essentially the same methodology, but different base-
line estimates.
These observations confirm the need to account for
inhomogeneity among studies and variations in study
quality in a meta-analysis of these studies. In this paper
we investigate alternative methods for doing this, based
not on crude overall or individual study adjustment, but
on integrating information about quality issues into the
likelihood itself.
3.1 Exchangeable Meta-Analyses
Consider simple pooling of the data into two large
studies with aggregate counts (n+ce, n+ce¯, n
+
c¯e, n
+
c¯e¯) of
(1617, 946, 3499, 2424) for the case-control studies
and (259, 108, 176 143, 147 192) for the cohort stud-
ies. With Be(1/2,1/2) reference priors on the pairs of
conditional probabilities (pe|c, pe|c¯) and (pc|e, pc|e¯),
respectively, the posterior distributions for the expo-
sure log odds ratio εLOR, with likelihood given exactly
in (2) and (6), are indistinguishable from the normal
approximations with means and standard deviations
[(3) and (4)] of 0.1690 ± 0.0487 for the case-control
studies and 0.6951 ± 0.1146 for the cohort studies.
Fixed- and random-effects analyses, using Markov
chain Monte Carlo (MCMC), give overall estimates
for εLOR of 0.2072 ± 0.0471 and 0.2849 ± 0.1958, re-
spectively. The mean exposure probabilities and mean
case probabilities are similar to those from the pooled
estimates, but the standard deviations are substantially
larger, reflecting variability among the studies. Pos-
terior distributions of individual study log odds ra-
tios εiLOR and classification probabilities (pie|c and pie|c¯
for CCS; pic|e and pic|e¯ for CHS) are also available from
this methodology.
A partially exchangeable random-effects model can
be constructed to accommodate the heterogeneity of
country groups simply by employing a hierarchical
prior distribution for the study-specific log odds ra-
tios εi , allowing for country-group-specific effects that
arise from such sources as varying exposure standards,
intensities of spousal smoking and ambient air stan-
dards. Results from such a model are presented in Sec-
tion 4.1.
3.2 Nonexchangeable Models: Quality Adjustment
The assumption of exchangeability that is implicit
in all the methods of Section 3.1 seems untenable
in light of the acknowledged heterogeneity of the
29 ETS studies. We now turn to implementing the
new methods for synthesizing heterogeneous evidence
presented in Section 2. While the studies differ in
many ways, we address the three specific examples
of nonexchangeability described in Sections
2.2.1 and 2.2.2 to illustrate how these methods for ad-
justing likelihoods may be used to improve inference.
Each subject is classified three times: first for eligi-
bility (never-smoking female), then for disease (lung
cancer case) and then for exposure (married to a
smoker) in an order that depends on the study de-
sign (CCS or CHS). Altogether there are eight possible
classifications, and through errors any of these could be
(mis)classified as any other. In our approach we model
explicitly the latent true population proportions pijk

with case status j ∈ C ≡ {c, c¯} (case and noncase), ex-
posure status k ∈ E ≡ {e, e¯} (exposed and unexposed),
and eligibility status 
 ∈ S ≡ {s, s¯} (ineligible, i.e.,
ever-smoker, and eligible, i.e., never-smoker). As in
Section 2.2 we denote by αij |k the conditional proba-
bility that a subject in study i of true case/exposure/
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eligibility class k will be misclassified as class j for
j, k ∈ CES, and find that study i gives direct evidence
only about (some aspects of ) the apparent classifica-
tion probabilities
qij =
∑
k∈CES
αij |kpik, j ∈ CE ,
for apparently eligible subjects, through their individ-
ual likelihood functions
LiCCS(q
i) ∝ (qie|cs¯ )n
i
ce (1 − qie|cs¯ )n
i
ce
· (qie|c¯s¯ )n
i
c¯e (1 − qie|c¯s¯ )n
i
c¯e¯ ,
(16)
LiCHS(q
i) ∝ (qic|es¯ )n
i
ce (1 − qic|es¯ )n
i
c¯e
· (qic|e¯s¯ )n
i
ce¯ (1 − qic|e¯s¯ )n
i
c¯e¯ .
We now turn to estimating the classification prob-
abilities αij |k needed to make inference about the
true population-based classification probabilities pik
and, through them, the true relative risk of expo-
sure pc|es¯/pc|e¯s¯ , the nearly identical exposure odds ra-
tio Re = pce|s¯pc¯e¯|s¯/pce¯|s¯pc¯e|s¯ or its logarithm εLOR =
logRe.
Denote by θi the vector θi = {θice, θ ice¯, θ ic¯e, θ ic¯e¯} of
true classification probabilities for eligible members of
each study population (these are just the conditional
classification probabilities θice = pice|s¯ , etc.). For the
purpose of the present analysis, based on the availabil-
ity of information about classification reliability in the
29 studies we consider, we make the provisional sim-
plifying assumption that double and triple misclassi-
fications are sufficiently rare to be negligible, and we
consider only the possibility of at most one misclassi-
fication per subject. Under this simplification only four
true classifications contribute to each apparent one, and
(14) and (15) lead to a simple expression for the proba-
bility of being classified (rightly or wrongly) in the ith
study as an eligible exposed case,
qices¯ ≈ αis¯|cespices + αices¯|ces¯pices¯
+ αie|ce¯s¯pice¯s¯ + αic|c¯es¯pic¯es¯(17)
= αis¯|cespices
+ (αices¯|ces¯θ ice + αie|ce¯s¯θ ice¯ + αic|c¯es¯θ ic¯e)pis¯ ,
as the sum of the probabilities of being in fact an
ineligible exposed case or of being an eligible sub-
ject who is an exposed case (correctly classified), an
unexposed case (with misclassified exposure) and an
exposed noncase (with misclassified case status), re-
spectively. Similar expressions are available for qice¯s¯ ,
qic¯es¯ and qic¯e¯s¯ , and from them, the derived conditional
probabilities qie|cs¯ and so forth that appear in the like-
lihood functions (16). We now turn to the problem of
identifying the parameters needed to make inference
about θi and Rie from (16) and (17): the smoking preva-
lences pis , smokers’ classification probabilities pij |s
and classification probabilities αij |k , for j, k ∈ CES.
3.2.1 Ever-smoking prevalence and classification.
Estimates of the study-specific population ever-
smoking prevalences pis are given in EPA Review
(1992, Table B-11). Ever-smokers’ exposure proba-
bility pie|s = Kθie/(Kθie + θie¯) is available from the
never-smokers’ exposure probability pie|s¯ = θie =
θice+θic¯e and the marriage concordance K ≡ (pes pe¯s¯ )/
(pes¯ pe¯s), reflecting the propensity of spouses to have
similar smoking habits. We follow Lee (1992, pages
158–160 and Table 3.40), who found K ≈ 3, although
estimates as high as 5.52 have been reported in the lit-
erature (Ogden et al., 1997).
Because the relative risk of lung cancer associated
with active smoking in the ith study, Ris , is in general
much higher than any that might be associated with
passive exposure to environmental tobacco smoke (see
EPA Review, 1992, Table B-11) we take ever-smokers’
case probabilities pic|es and pic|e¯s not to depend on ex-
posure status and to be given by pic|s = Rispic|s¯ ; see
Section 4.3 for further comments. Since the overall
cancer rate may be written pic = pic|spis + pic|s¯pis¯ =
pic|s¯ (pisRis + pis¯), ever-smokers’ and never-smokers’
cancer rates may be computed as
pic|s =
picR
i
s
pisR
i
s + 1 − pis
,
(18)
pic|s¯ =
pic
pisR
i
s + 1 − pis
from the reported smoking prevalence pis , smokers’
relative risk Ris (EPA Review, 1992, Table B-11) and
overall cancer rate pic (EPA Review, 1992, Table C-2).
Together, these values of pis , pie|s , pic|es and pic|e¯s de-
termine all four ever-smokers’ classification probabili-
ties pijs , j ∈ CE .
Now we turn to the classification probabilities αij |k ,
which depend on how well each study addressed the
difficulties of correct classification, that is, on study
quality.
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3.2.2 First study quality adjustment: Eligibility vio-
lations. Each of the 29 studies we considered requires
its eligible subjects to be never-smoking females; nev-
ertheless, for the reasons discussed at the beginning of
Section 3, one must expect a small number of current or
former smokers to be erroneously included in some of
the studies. In this section we implement the method
presented in Section 2.2.1 of adjusting the analysis to
eliminate the bias and to reflect added uncertainty.
First we need to find the study-specific and case–
exposure class-specific probabilities p
‘s¯’|s that ever-
smoking individuals in the population from which the
ith study sample is drawn misrepresent their smok-
ing status as “never-smoker.” From Lee (1992, Ta-
ble 3.38) and in accord with other estimates (Tables
3.36 and 3.37 of Lee, 1992; Table B-3 and the dis-
cussion on pages B-8–B-13 of EPA Review, 1992),
we estimate that about 5% of ever-smokers deny ever
smoking. The EPA Review and Lee considered sep-
arately the effects of misclassified regular smokers
and occasional smokers; in the present analysis we do
not distinguish these subclasses of ever-smokers. Lee
(1992, pages 156–157) suggested that the denial rate
among cancer subjects may be a bit lower, while the
EPA Review (1992, page B-10) and (paradoxically)
Lee (1992, page 151) reported evidence of “markedly
higher” denial rates among lung cancer patients than
among the general population. In light of this discrep-
ancy, we take them not to depend on case status (see,
however, the discussion in Section 4.3).
There appears to be little evidence about whether
smoking misclassification rates vary with exposure sta-
tus. One might imagine that exposed subjects (i.e.,
those married to a smoker) might be more likely to dis-
count any former or occasional smoking, and represent
themselves as never-smokers. Conversely, one might
imagine that unexposed subjects find more social pres-
sure to deny former or occasional smoking. We explore
sensitivity to this aspect in Section 4.3, but following
the speculation of Lee (1992, page 157), we make the
provisional assumption that smoking misclassification
rates do not depend on exposure status.
The EPA assigns “penalty points” Ai ranging from
−0.5 (a bonus) to +1.0 for each study’s control of this
source of bias (EPA Review, 1992, Table A-2). We take
error rates to be approximately 5% for typical studies,
and to double with each successive penalty point, lead-
ing to
αis¯|ces = αis¯|ce¯s = αis¯|c¯es = αis¯|c¯e¯s = 0.05 × 2Ai .(19)
3.2.3 Second study quality adjustment: Misclassifi-
cation of exposure. Next we need to find the study-
and case status-specific probabilities p
‘e’|e¯ and p‘e¯’|e
that eligible (never-smoking female) individuals have
their exposure status misclassified. A few studies report
estimates of the other conditional exposure misclassi-
fication probabilities—pe¯|‘e’, for example, the fraction
of women with negligible exposure among those clas-
sified as exposed. We use Bayes’ theorem to invert
the conditioning below. Friedman, Petitti and Bawol
(1983) estimated that 47% of currently nonsmoking
wives of smokers have negligible (less than 1 per day)
exposure at home, and that 40–50% of women with
nonsmoking spouses have significant ETS exposure (in
the workplace, e.g.). In contrast, Lee (1992, page 130)
said that exposure misclassification “does not seem
likely to be a major issue,” and Jarvis et al. (2001) ar-
gued that “married to a smoker” is a good surrogate
for “exposed.” We interpret Lee’s and Jarvis et al.’s
remarks as a suggestion that approximately 0–5% of
women have misclassified exposure status, and we
use nominal values of pe¯|‘e’ = 0.25 and pe|‘e¯’ = 0.10
as a compromise. Although Lee (1992, Table 3.41,
page 161) offered an estimate of 22.5% for the over-
all apparent exposure rate p
‘e’, the empirical rates for
the individual studies we considered ranged from 15 to
87% in the EPA Review (1992, Table 5.2, pages 5-6–
5-7). Consistent with these values, we take a nom-
inal value of 0.36 for p
‘e’ (approximately the sam-
ple median), leading to pe = p‘e’pe|‘e’ + p‘e¯’pe|‘e¯’ =
0.3340, pe¯ = 1 −pe = 0.6660, p‘e¯’|e = p‘e¯’ pe|‘e¯’/pe =
0.1916 and p
‘e’|e¯ = p‘e’ pe¯|‘e’/pe¯ = 0.1351, irrespec-
tive of case status. Thus about 14% of never-smoking
women with negligible exposure to others’ tobacco
smoke are married to smokers and so are treated in the
studies as “exposed,” while almost 20% of women ex-
posed to tobacco smoke do not have smoking spouses,
but rather are exposed from other sources. The EPA as-
signs penalty points Bi ranging from −0.5 (a bonus)
to +2.5 for each study’s control of this source of bias
(EPA Review, 1992, Table A-2). We take these rates to
apply to those studies with the least control over ex-
posure misclassification, and again take error rates to
double with each successive penalty point, leading to
study-specific misclassification probabilities of
αie¯|ces¯ = αie¯|c¯es¯ = 0.1916 × 2Bi−2.5,
αie|ce¯s¯ = αie|c¯e¯s¯ = 0.1351 × 2Bi−2.5.
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3.2.4 Third study quality adjustment: Misclassifica-
tion of cases. The final classification error we consid-
ered is that of misclassification of lung cancer. We need
to find the study- and exposure-specific probabilities
p
‘c’|c¯ and p‘c¯’|c that eligible individuals have their case
status misclassified. The EPA Review (1992) attempted
to classify studies with respect to their ability to control
this source of bias through the use of histological ver-
ification. Although lung cancer misdiagnosis rates are
known to differ for smokers and nonsmokers, there is
no evidence or suggestion that they differ with respect
to ETS exposure. Lee (1992, page 129) cited stud-
ies in which 30–40% of lung cancers seen at autopsy
are missed clinically. We take a nominal false-negative
misclassification rate of 0.35, which we reduce for
each study by the fraction Ci of cases histologically
verified (Table 5-4 of EPA Review, 1992; Table 3.3
of Lee, 1992). The fraction of false positives is less
than the overall lung cancer rate, negligibly small in
the present context. Thus,
αic|c¯es¯ = αic|c¯e¯s¯ ≈ 0,
αic¯|ces¯ = αic¯|ce¯s¯ = 0.350 × (1 − Ci).
3.2.5 A hierarchical prior distribution. To complete
our Bayesian model formulation it remains only to
specify the joint prior distribution of the {θi} and any
features of interest, such as a measure ε of exposure
effect. Since θi can be recovered from θic = θice + θice¯,
θie = θice + θic¯e and εiLOR by solving for θice in the
quadratic relationship
exp(εiLOR) =
θiceθ
i
c¯e¯
θ ice¯θ
i
c¯e
= θ
i
ce(1 − θic − θie + θice)
(θ ic − θice)(θ ie − θice)
,
we construct the joint distribution for θi from that of
θic , θ
i
e and εi .
We employ a similar prior normal hierarchical dis-
tribution for the logistics log(θ ic/θ ic¯) of the cancer rates
θic = θice + θice¯ for eligible subjects in the studies, cen-
tered at conditionally independent country-group lev-
els which are centered in turn at an overall level with
prior mean the population-wide lung cancer rate, ap-
proximately 25/105, with low (0.5) precision at each
level to express very little prior opinion about never-
smokers’ cancer rates pic|s¯ .
From our earlier estimate of p
‘e’ ≈ 0.36 and observa-
tion that reported (apparent) exposure rates vary from
15 to 87%, we assign independent normal prior distri-
butions with mean µe ≈ log(0.36/0.64) = −0.57 and
variance σ 2e = 0.842 to the logistic of each θie , chosen
to ensure that P[0.10 < θie < 0.75] ≈ 90%.
We assign conditionally independent normal dis-
tributions to the study-specific log odds ratio εiLOR =
log(θ iceθ ic¯e¯/θ
i
ce¯θ
i
c¯e), centered at a country-group-
specific level εg . The country-group means εg are
drawn from a normal distribution centered at an over-
all ε, whose distribution in turn is normal centered at
zero. The relative risk for active smokers, which re-
portedly ranges from Ris = 1.66–16.3 (EPA Review,
1992, Table B-11), is believed to exceed whatever rel-
ative risk [approximately exp(εiLOR)] may be associ-
ated with ETS exposure. Consistent with this we chose
overall country-group-level and individual-level vari-
ances σ 2
εO
= σ 2
εG
= σ 2
εI
= 0.33 to ensure a marginal
probability P[exp(εiLOR) > 10] ≈ 5% with correlation
of about 2/3 within each country group and about 1/3
for studies in different country groups.
4. QUALITY ADJUSTMENT RESULTS
Posterior distributions for the quantities of inter-
est in our Bayesian hierarchical model are not avail-
able in closed form, but are easily approximated
using MCMC (Besag, Green, Higdon and Mengersen,
1995; Gelfand and Smith, 1990; Gilks, Richardson
and Spiegelhalter, 1996; Tierney, 1994). Full condi-
tional distributions are available for parameters from
the overall and group levels of the hierarchy, allow-
ing us to use Gibbs sampling at those levels, while a
Metropolis–Hastings approach was used at the individ-
ual study level with proposal distributions drawn from
a symmetric Gaussian random walk with step sizes
chosen to attain an acceptance rate of about 30% for
proposed steps. The model is implemented in MatLab
(MathWorks, 2002); source code and data sets are
available from the authors upon request. Inference is
based on 2500 equally spaced samples of nearly inde-
pendent observations from runs of 10 million steps af-
ter a burn-in period of 1 million steps, which appears to
be more than adequate to ensure MCMC convergence.
4.1 Unadjusted Results
It is apparent from Figure 2 that the degree of asso-
ciation between lung cancer and ETS varies markedly
across country groups.
The model described in Section 3.2 with the misclas-
sification probabilities αij |k all set to zero for j = k,
j, k ∈ CE , reduces to the partially exchangeable model
introduced in Section 1.3, a hierarchical model in
which study-specific effects εi are taken to be simi-
lar within country groups. The posterior distributions
of the study-specific quantities εi are drawn away
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FIG. 2. Likelihood functions for country-group effects from the
EPA Review (1992, Table 5-7) for Greece, Hong Kong, Japan,
United States, Western Europe and China.
from their respective maximum likelihood estimates
(MLEs) εˆi = log(ncenc¯e¯/nce¯nc¯e) (or posterior means
ε¯i under independent reference prior distributions)
toward group level quantities εg , for i ∈ g, whose dis-
tributions in turn are drawn together toward an overall
level ε. This shrinkage effect, more pronounced for
smaller studies than for larger ones, is an expression of
the regression effect. Figure 3 illustrates this phenom-
enon, with MLEs indicated at the left (A), posterior ex-
pectations E[εi] in the left center (B), group posterior
FIG. 3. Individual exposure odds ratios Rie = exp(εi ): (A) MLE,
(B) posterior mean, (C) posterior group mean and (D) overall ef-
fect (with posterior pdf ) in a hierarchical model without quality
adjustment (all on log scale).
FIG. 4. Posterior density of overall exposure odds ratio in a hi-
erarchical model without adjustment, with posteriors from naive
pooling, from a fixed-effects model and from a random-effects
model.
expectations E[εg] in the right center (C) and the over-
all posterior mean E[ε] at the right (D). Note the wide
variability of the posterior distribution for ε, shown as
a probability density function.
Figure 4 shows the posterior distribution for the
overall exposure odds ratio Re ≡ exp(ε) with no ad-
justment (thick solid line), overlaid with the poste-
rior distributions from naïve pooling of CCS and CHS
studies (dash–dot and dashed thin lines), and from
the fixed-effects and random-effects models of Sec-
tion 3.1 (dash–dot and dashed thick lines). Individ-
ual study MLEs are shown on the horizontal axis as
downward tickmarks (for CCS) and upward tickmarks
(for CHS), with lengths proportional to precision (i.e.,
larger studies exerting more influence on the overall
posterior distributions are indicated by larger symbols).
Note the larger variability of the hierarchical random-
effects model compared with the simple pooling and
fixed-effects models, more accurately reflecting all the
sources of variability and uncertainty, and its general
similarity with the (still more widely dispersed) poste-
rior density for the unadjusted model.
4.2 Adjusting Study Evidence for Quality
Variations
Studies differ in their degrees of effort and lev-
els of success in addressing each of the three types
of misclassification discussed in Section 3. We inves-
tigate the impact of adjustment for misclassification
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in two stages: first for eligibility and then for expo-
sure and case status. The marriage concordance (Lee,
1992, pages 158–160) led many investigators (e.g.,
Lee, 1992, pages 143–145; EPA Review, 1992, Sec-
tion 5.2.2, pages 5-22–5-25 and Table 5-8) to expect
that disproportionately many exposed subjects in case-
controlled studies would be ever-smokers misclassified
as never-smokers, creating a bias that elevated the ap-
parent association between lung cancer and ETS. We
thus anticipated that properly adjusting for eligibility
misclassification would reduce this bias and show a
smaller degree of association.
Figure 5 shows the posterior means for the study-
specific exposure odds ratios E[Rie ≡ exp(εi)] within
the unadjusted model (as in Figure 4) on the left (A),
adjusted for eligibility in the middle (B) and adjusted
for all misclassifications on the right (C). Evidently,
our adjustment for eligibility misclassification led to
a very slight reduction in apparent association between
ETS and lung cancer (the mean dropped from 1.301
to 1.291), while subsequent adjustments for case and
exposure misclassification led to slight reductions for
some studies and slight increases for others, and gener-
ally to slight increase in mean with a much larger vari-
ability (95% CI widened and rose from [0.800,2.066]
to [0.845,2.224]), contrary to our anticipation of a con-
sistent downward trend, but consistent with an earlier
analysis (EPA Review, 1992, Table B-11) and the re-
cent observation of Boffetta (2002) that several sources
of bias may lead to both overestimation and underesti-
mation of true association.
FIG. 5. Posterior means of exposure odds ratios Rie in a hierar-
chical model (A) without adjustment, (B) adjusted for eligibility
misclassification and (C) adjusted for all misclassifications.
4.2.1 A tale of two studies. We illustrate the effects
of adjustment by examining how it affects the evi-
dence from two studies, a Tier 4 CCS study (4, CHAN)
from country group HK and a Tier 2 CHS study (28,
HIRA) from country group JP (quality tiers and coun-
try groups assigned by the EPA Review, 1992, are re-
produced in Table 1). Case-control studies offer evi-
dence about the population exposure rate θie , but due
to their design, give no evidence about the population
case rate θic . Conversely, cohort studies offer evidence
about θic , but not θie . Thus the posterior distributions
for these quantities differ markedly for the two de-
signs. Data proportions (nc/n+, ne/n+) are indicated
in Figure 6 by solid and dashed vertical lines, respec-
tively. Posterior distributions for the quantities not illu-
minated by the data (θic for CCS; θie for CHS) remain
close to their prior distributions (also shown in Figure 6
as unshaded curves).
Study evidence bears directly on the two apparent
conditional probabilities that govern the arms of the
study—qie|c, qie|c¯ for CCS and qic|e, qic|e¯ for CHS.
Figure 7 shows the likelihood functions for qc|e and
qc|e¯ for the arms of CHS study 28 (HIRA) as a dot-
ted line, along with their posterior distributions in our
hierarchical model (dashed lines) and those of the
study-specific true classification probabilities for eli-
gible subjects, θic|e and θic|e¯ (solid lines). Notice that
the likelihood (dotted curve), representing a face-value
acceptance of the immediate evidence without consid-
ering possible eligibility and classification errors, is far
FIG. 6. Prior and posterior distributions for θic and θie for CCS
and CHS studies on (separate) logistic scales.
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FIG. 7. Likelihood functions and posterior probabilities for can-
cer case probabilities within exposed and unexposed arms of a
CHS.
narrower than the other curves which reflect the possi-
bility that (through misclassification) the study’s sam-
ple misrepresents its population and that the apparent
probabilities qi lie closer to the immediate evidence
of the likelihoods than do the study-specific estimates
of the population-based classification probabilities θi .
Figures for CCSs and CHSs are similar; the plot for
the qi posterior distributions are broader than their
likelihoods, but centered at the same location, while the
plots for the θi ’s are very similar to those for the qi’s
for studies with low misclassification rates (where ad-
justment for possible classification errors has little
effect) and are often shifted for studies with higher mis-
classification rates (where adjustment effects are more
pronounced).
Posterior distributions for the study-specific log odds
ratios εiLOR are drawn toward the country-group mean
for both types of studies. Thus in Figure 8 the “un-
adjusted” posterior distribution (solid line) is shifted
a bit to the right from the likelihood function (dashed
line) in the direction of the group mean. Unexpectedly,
adjustment for eligibility violations (dotted curves)
makes little net change for either of these studies; ad-
justment for misclassification of case and exposure sta-
tus (dashed curves) makes a slightly larger impact,
broadening the CCS study slightly and shifting the
CHS study a bit to the right.
4.3 Sensitivity
The process of building Bayesian models is really
dynamic. There is no hope of modeling explicitly
FIG. 8. Likelihoods and posterior pdf ’s for εi for CCS and CHS
studies on (separate) log scales, with different degrees of adjust-
ment.
everything that is uncertain and that affects inference
to any degree, however small. The decisions about ex-
actly which features to model as uncertain, requiring
the specification of a conditional prior distribution and
increasing the dimension of the subsequent posterior
integration, are based on judgement or evidence about
how sensitive our posterior inference is to their inclu-
sion.
In Section 3.2 we described our approach to find-
ing suitable estimates for the many quantities needed
to adjust the 29 studies we consider and make them
more nearly comparable—the smoking prevalences pis ,
smokers’ classification probabilities pij |s , the misclas-
sification rates αij |k for j = k, j, k ∈ CES, and the
means and precisions needed in our three-level hierar-
chical logistic normal model for (εi, θ ic, θ ie). The ETS
case study we present here is unusual in that so much
hard work has been done by others (particularly by Lee
and by the EPA Review panel) to assess and quantify
population and study features in copious detail. Some
of these quantities are known with less certainty than
others. In this section we explore sensitivity to some of
the choices we made— smoking prevalances and some
misclassification rates.
In Section 3.2.3 we based estimates of the typi-
cal exposure misclassification rates p
‘e¯’|e ≈ 0.1916 and
p
‘e’|e¯ ≈ 0.1351, and true exposure rate of pe ≈ 0.3340,
on nominal literature values of p
‘e’ ≈ 0.36 for the
overall apparent exposure rate and pe¯|‘e’ ≈ 0.25 and
pe|‘e¯’ ≈ 0.10 for the true exposure misclassification
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probabilities for those classified as exposed and un-
exposed, respectively; each of these nominal literature
values was a compromise from widely varying liter-
ature estimates. If instead we were to take literally
the apparent exposure estimate p
‘e’ ≈ 0.225 from Lee
(1992, Table 3.41, page 161; well below the reported
exposure rates among our studies), and the misclas-
sification rate estimates of pe¯|‘e’ ≈ 0.47 and pe|‘e¯’ ≈
0.40–0.45 from Friedman, Petitti and Bawol (1983)
(ignoring the contrary evidence of Lee, 1992, page 130,
and Jarvis et al., 2001) we would find the far higher
error probabilities p
‘e¯’|e ≈ 0.7474 and p‘e’|e¯ ≈ 0.1970
and higher true exposure rate of pe ≈ 0.4678.
This would distort our inference about quantities of
interest such as the overall odds ratio Re = exp(εLOR);
point estimates would rise from the value Re ≈ 1.374
we find in the present analysis to as high as 1.87 with
these (untenable, as we will see) values. CHS study
28 (HIRA) reported nce = 163 cases among ne =
69,645 apparently exposed subjects, and nce¯ = 37
cases among nc = 21,895 apparently unexposed ones.
It is impossible to reconcile these with error rates
as high as p
‘e¯’|e ≈ 0.7474, p‘e’|e¯ ≈ 0.1970; the num-
bers mj of subjects with true case–exposure clas-
sification j ∈ CE are related to those of apparent
classification k ∈ CE by a linear relationship nj =∑
αj |kmj , whose solution mˆ for these error probabil-
ities and case-counts would give mˆce ≈ 318.2 cases
among mˆe ≈ 57,309 truly exposed subjects, about dou-
ble the reported rate, and mˆce¯ ≈ −10 cases among the
mˆe ≈ 10,657 truly unexposed ones, an obvious impos-
sibility.
In Section 3.2.2 we recounted the contradictory ev-
idence and published opinion about whether and how
eligibility misclassification rates might vary with case
and exposure status. The results presented in Figure 5
are based on the assumption that eligibility misclassi-
fication rates do not vary with status [see (19)]. In a
sensitivity analysis we explored the consequences of
changing this assumption, taking the eligibility mis-
classification rates αs¯|js to vary with case–exposure
status j ∈ CE . A surprising sensitivity was revealed,
particularly to the possibility of rates that vary with ex-
posure status.
Under the hypothetical assumption of no true asso-
ciation between lung cancer and ETS, Re = 1, a wide
variety of eligibility misclassifications will all lead
to an apparent positive association Rˆe > 1 (Tweedie,
Mengersen and Eccleston, 1994). It is perhaps surpris-
ing that, for true values Re > 1, differential eligibility
FIG. 9. Sensitivity of odds ratio inference to exposure-specific el-
igibility misclassification rates.
misclassification can distort the evidence in either di-
rection. We can illustrate the point with an artificial ex-
ample.
The top portion of Figure 9 illustrates the effect of
various possibilities about eligibility misclassification
rates for a true odds ratio of Re = 1 (i.e., if ETS and
lung cancer were unrelated); each of the curves lies
above the horizontal line at Re ≡ 1, indicating that in
all cases the effect of misclassification is to inflate the
apparent association. However, if the true odds ratio
were Re ≈ 1.3, a value consistent with many of the es-
timates reported in the literature, the bottom portion
of Figure 9 illustrates that if unexposed subjects were
to have double the eligibility misclassification rate of
exposed ones (perhaps from social pressure to deny
smoking), then the apparent association would fall
from Rˆe ≈ 1.30 to Rˆe ≈ 1.22 as the exposed-subject
eligibility misclassification rate rises from αs¯|ce = 0
to 0.10 (dashed line), distorting the apparent relative
risk downward. Conversely, if exposed subjects were
to have half the eligibility misclassification rate of un-
exposed ones (perhaps because their occasional smok-
ing seems insignificant), then the apparent association
would rise from Rˆe ≈ 1.30 up to the inflated figure
of Rˆe ≈ 1.63 (dotted line in Figure 9). Equal decep-
tion rates also show an inflation in apparent association
(dash–dot line).
Evidently risk estimates are quite sensitive to the
very uncertain feature of possible variation of smok-
ing denial rates with exposure status. Uncertainty about
these rates poses an obstacle not only to synthesizing
evidence from several studies, but even to interpreting
the evidence of a single study. Our observed sensitivity
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of the model to “apparently innocuous assumptions” is
supported by the findings of Higgins and Spiegelhalter
(2002) in a comparison of the inferences that arise from
a meta-analysis and those from a megatrial.
It is of course possible to reflect uncertainty about
the deception rates within our modeling framework by
adding a new level of model hierarchy and introducing
a joint prior distribution for the deception rates {αis¯|js}
and misclassification rates {αij |k} as in (13), but we do
not pursue that further here.
5. DISCUSSION
The hierarchical Bayesian approach described in this
paper provides a new flexibility in meta-analysis by fa-
cilitating the formal adjustment of evidence for varia-
tions in important factors such as quality and design at
the study-specific level. The nonexchangeable models
advocated here accommodate such study-specific het-
erogeneity through careful specification of joint prior
distributions for study-specific parameters that adjust
directly the evidence from each study’s likelihood.
This coherent, likelihood-based approach is arguably
superior to alternative approaches such as naively com-
bining reported values without any adjustment, dis-
counting or excluding some or all studies on the basis
of perceived problems of quality or study design, or in-
voking (often unsupportable) exchangeability assump-
tions in more traditional random effects models or
making often arbitrary adjustments at a broad scale.
Note that the need for adjustment and the size of its
effect do not diminish for large studies—a study with a
high misclassification rate will give distorted or biased
evidence, no matter how large its sample size.
Other methods for combining the evidence from
disparate studies have been suggested in the litera-
ture. For example, Thompson and Sharp (1999) pro-
posed weighted regression in place of a hierarchical
model for obtaining estimates of effect size for dif-
ferent covariate values. A multivariate meta-regression
analogue of this approach could be developed for the
ETS case study (as suggested by a referee). Alterna-
tively, the problem could be cast in the form of a mea-
surement error model (Cheng and Van Ness, 1999), in
which each study’s results are treated as measurements
(with error) of model parameters. A related approach
is adopted by Aitchison (1977, 1979), who used inter-
clinic calibration data to combine studies from multiple
clinics that differ in their methods of measurement of
diagnostic features.
The unadjusted estimates in the present meta-
analyses of the relative risk of lung cancer associ-
ated with ETS exposure are consistent with the results
of other published meta-analyses (Wald et al., 1986;
National Research Council Committee on Passive
Smoking, 1986; Tweedie and Mengersen, 1992; EPA
Review, 1992; Lee, 1992; OSHA, 1994; Hackshaw,
Law and Wald, 1997; Boffetta et al., 1998; Zhong,
Goldberg, Parent and Hanley, 2000; Boffetta 2002).
For example, Hackshaw, Law and Wald (1997) esti-
mated Re ≈ 1.24 (1.13–1.36), based on 37 studies;
Zhong et al. (2000) reported Re ≈ 1.20 (1.12–1.29)
based on 35 case-control and five cohort studies;
Boffetta et al. (1998) reported Re ≈ 1.16 (0.93–1.44)
in a multicenter European study; and Boffetta (2002)
found an overall relative risk of Re ≈ 1.25 (1.15–1.37)
based on 51 relevant studies that comprised 7369 ob-
served cases of lung cancer. A very recent reanalysis
by Enstrom and Kabat (2003) of the large American
Cancer Society’s first cancer prevention study reported
a point estimate less than unity and thus an overall
null effect. Moreover, the adjusted point estimates are
in broad agreement with those that adjust using less
formal methods, although our 95% credible interval
(0.845–2.224) is somewhat wider because our hierar-
chical Bayesian approach is more faithful in represent-
ing multiple sources of uncertainty. It is clear that the
data set considered here, despite its age, provides a ve-
hicle for making relevant contributions to the current
ongoing debate about the association between ETS and
lung cancer.
Of course sources of bias other than study quality
may influence the results of this or any other meta-
analysis. For example, a topical issue is the potential
influence of publication bias, that is, the differential
tendency to publish small studies that show a positive
(whether or not significant) effect, but not to publish
small studies that show a negligible or negative effect.
An attempt to “control” the quality of included stud-
ies by restricting meta-analysis to published studies
may exacerbate the effects of publication bias, lead-
ing to spuriously high estimates of overall relative risk.
Controversy surrounds the potential influence of this
source of bias for the issue examined in this paper. Lee
(1992, page 166) stated that “overall, it appears that
some publication bias has occurred, and that it can ex-
plain a part, but by no means all, of the observed asso-
ciation.” Givens, Smith and Tweedie (1997) proposed
a data-augmentation method to simulate the results of
unobserved studies within a hierarchical model and
concluded that the overall association between ETS
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and lung cancer in nonsmoking women may be over-
stated by around 30%, in both U.S. and global studies.
A trim-and-fill funnel plot approach taken by Duval
and Tweedie (2000a, b) led to a similar conclusion
of overstatement. Copas and Shi (2000) similarly ar-
gued that the overall excess risk of 24% reported by
Hackshaw, Law and Wald (1997) could be reduced to
15% after taking into account this form of bias. The en-
suing debate over these papers (see the corresponding
discussions) has refuted these claims strongly, arguing
that they overestimate the number of missing studies
and their impact.
Other quality issues not considered in the present
analysis include confounding with dietary factors (sug-
gested by Boffetta et al., 1998, but later disputed by
Brennan et al., 2000), genetic susceptibility (Bennett
et al., 1999) and variable length of exposure (Nyberg
et al., 1998), leading to bias through right censoring.
Our approach offers a number of advantages over
earlier ones. First, it requires very strict and explicit
identification of the factors for which adjustment is to
be made. This necessitates a strong audit trail of the
rationale behind the proposed adjustment, the source
and degree of detail of the evidence at a study-specific
level and an acknowledgment of the uncertainty of the
proposed adjustment. These in turn guide the expres-
sion of the adjustment in the model and the level of the
hierarchy to which it will be applied.
A second advantage afforded by the proposed ap-
proach is an introspection about the impact of the
claimed evidence, at both study-specific and global lev-
els. This was illustrated in the ETS analysis through the
sensitivity assessments of Section 4.3. The model nat-
urally afforded a formal assessment of the surprising
sensitivity to differential case and exposure misclas-
sification, and the inapplicability at the study-specific
level of some published estimates of exposure misclas-
sification. Importantly, a consequence of these require-
ments for detailed evidence from trusted sources and
an understanding of the implications of the choice of
evidence is a healthy respect for meta-analysis in gen-
eral and a careful regard for interpretations made on
the basis of it.
Care must be taken in interpreting published esti-
mates of error rates. Usually investigators report esti-
mates of the fraction of the sample that is misclassified
(e.g., report P[s¯|‘s ’]), whereas likelihood-based adjust-
ment methods like ours require the fraction of the pop-
ulation that is liable to misclassification (e.g., P[‘s¯ ’|s]).
These differ whenever P[s] = P[‘s ’], as in our exam-
ple (smokers deny smoking far more often than never-
smokers claim to smoke). In Section 3.2.3 we illustrate
how to calculate the needed quantities from those usu-
ally available.
A third advantage is that we are able to make
probabilistic statements impossible under the earlier
approach (Lee, 1992; EPA Review, 1992). We can
find posterior distributions of any quantities of in-
terest (not just model parameters, but arbitrary func-
tions of them) at any hierarchy level of the model or
we can find various point estimates (means, medians,
etc.) and statements of associated uncertainty (cred-
ible intervals, posterior standard deviations, etc.). In
the ETS analysis, for example, the prior probability
of any positive association between lung cancer and
ETS is P[ε > 0] = 1/2. Upon shrinking study evi-
dence toward country groups (but not yet adjusting for
quality), this rises to P[ε > 0] = 0.851; upon adjust-
ing for eligibility violations, it rises imperceptibly to
P[ε > 0] = 0.856; and with all quality adjustments, it
rises to P[ε > 0] = 0.907. Cancer odds are unlikely to
increase by as much as a factor of 2. However; there is
over a 90% chance that the relative risk of cancer asso-
ciated with never-smoking women married to smokers
is less than twice that of never-smoking women mar-
ried to nonsmokers. Thus on the basis of this analysis
the case for an association between ETS and lung can-
cer is strong, but evidence of a sizeable effect is not
compelling.
A fourth advantage is that we can use collateral in-
formation at whatever is the most appropriate level—
individual study, country group or overall—and that
our MCMC-based implementation makes it easy to
make detailed probabilistic statements about features
of inferential importance at any of these levels. Mul-
tiple comparisons that are largely inaccessible under
other paradigms are achieved here in a straightforward
manner. For example, in the ETS model without ad-
justment for misclassification, P[εUS = maxg∈G{εg}] =
0.11, whereas P[εGR = maxg∈G{εg}] = 0.40 and
P[εGR > εUS] = 0.69.
The fifth advantage is the approach’s simplicity and
flexibility. The number and nature of levels of hierar-
chy can be tailored to the needs of a particular problem,
and adjustment (like those we applied for classifica-
tion errors) may be imposed at any level(s) of that
hierarchy. The top level θ of the hierarchy can be
any hyperparameter conditional on which the study-
specific parameters {θi} are independent; in some cases
this may be the parameter θ0 that governs an “ideal”
trial for a particular investigator’s purposes, as in Sec-
tion 2.1, but in other cases it may be more abstract.
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Our estimates of misclassification rates (leading in
our linear parametric adjustment approach to the clas-
sification matrix α) are an easily interpreted and public
part of our analysis. Investigators who disagree with
our choices (e.g., those who disapprove of our simpli-
fying assumption of no multiple misclassifications) are
free to substitute their own and explore the same evi-
dence in the light of their different assumptions.
Finally, the type of adjustment itself is also flexi-
ble, in that one is able to parameterize whatever vari-
ations exist among studies under study and express
uncertainty about those variations (perhaps in a nonex-
changeable fashion) in the form of joint prior distri-
butions. The computational feasibility of the MCMC
algorithm that implements the approach, which in the
ETS example translated into the ability to complete
million-step runs in under half an hour on a lap-
top computer, allows the investigator to explore such
modifications interactively, with appropriate assess-
ment of convergence and sensitivity. This interactive
exploratory model-building with complete representa-
tion of uncertainty is a powerful tool for interpreting
and synthesizing evidence from multiple sources.
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